Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03242564 · ClinicalTrials.gov registry record · NA

Effects of Red Light LED Therapy on Body Contouring

A NA study of Obesity, sponsored by Vevazz.

Completed
Registry status
NA
Development phase
66
Enrollment target
1
Study location

NCT03242564: Completed NA study of Obesity, sponsored by Vevazz.

NCT03242564 is a NA study of Obesity that has completed, run by Vevazz. The registered enrollment target is 66 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03242564, a NA study of Obesity, has completed, sponsored by Vevazz.

COMPLETED
Registry status
NA
Development phase
66 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether red light therapy using LED 650nm red light for body contouring of the waist, hips and thighs is as effective as red light therapy using Laser 635nm red light.

Primary Outcome

Circumferential measurement of thighs, hips and waist before and after treatment.

Conditions Studied

Interventions

  • DEVICE Vevazz LED

Study Locations (1)

Texas

  • Vevazz, LLC - Dallas

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2017-07-10
Est. Completion 2017-07-21
Phase NA
Vevazz

1 total trials

What the finished NCT03242564 record still lists

NCT03242564 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Vevazz LED is the first listed.

NCT03242564 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT03242564 about?

NCT03242564 is a clinical study titled "Effects of Red Light LED Therapy on Body Contouring". The purpose of this study is to determine whether red light therapy using LED 650nm red light for body contouring of the waist, hips and thighs is as effective as red light therapy using Laser 635nm red light.

What is the current status of trial NCT03242564?

This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2017-07-10. Estimated completion is 2017-07-21.

What conditions does trial NCT03242564 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT03242564?

The interventions under investigation include: Vevazz LED (DEVICE).

Who is sponsoring clinical trial NCT03242564?

This trial is sponsored by Vevazz, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03242564 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03242564's enrollment target sits among peer trials

66 616th of 1053 higher than 433 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02584244 · 66 participants · Phase 1

    Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

  • NCT03067051 · 66 participants · Phase 1

    Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

  • NCT03754725 · 66 participants · Phase 1

    Ferritin and Iron Burden in SAH sIRB

  • NCT03875378 · 66 participants · Phase 2

    Transdermal Estrogen in Women With Anorexia Nervosa

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03242564, the US trial registry maintained by the National Library of Medicine. NCT03242564 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.